IGF1R Is a Potential New Therapeutic Target for HGNET-BCOR Brain Tumor Patients

(1) Background: The high-grade neuroepithelial tumor of the central nervous system with BCOR alteration (HGNET-BCOR) is a highly malignant tumor. Preclinical models and molecular targets are urgently required for this cancer. Previous data suggest a potential role of insulin-like growth factor (IGF)...

Descripción completa

Detalles Bibliográficos
Autores principales: Vewinger, Nadine, Huprich, Sabrina, Seidmann, Larissa, Russo, Alexandra, Alt, Francesca, Bender, Hannah, Sommer, Clemens, Samuel, David, Lehmann, Nadine, Backes, Nora, Roth, Lea, Harter, Patrick N., Filipski, Katharina, Faber, Jörg, Paret, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627083/
https://www.ncbi.nlm.nih.gov/pubmed/31234291
http://dx.doi.org/10.3390/ijms20123027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627083/
https://www.ncbi.nlm.nih.gov/pubmed/31234291
http://dx.doi.org/10.3390/ijms20123027

Ejemplares similares